drugset / Trial / NCT00311311

Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

NCT00311311

Phase 3 Terminated 72 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether immunosuppression by tacrolimus, mycophenolate mofetil, and prednisone compared to conversion to sirolimus, mycophenolate mofetil, and prednisone affect the progression of atherosclerosis in renal transplant recipients.

Timeline

Start
2006-04
Primary completion
2010-12
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sirolimus Small molecule 3 mg
Subject Tacrolimus Small molecule
Background Mycophenolate Mofetil Small molecule 500 mg Oral
Background Prednisone Other / unclassified 2.5 mg Oral